Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 10 | Rare Historical Photos

These 3 Stocks Are a Must When Building Your Dividend Portfolio

Since the uncertain economic conditions are expected to keep the stock market under pressure, dividend-paying stocks Pfizer (PFE), ICL Group (ICL), and ARC Document Solutions (ARC) could be solid additions to your portfolio for generating a steady income stream. Keep reading….

StockNews.com

Here Are 3 Stocks to Buy Under $50 in Q4

Although the stock market has been under pressure this year, many believe bulls will overtake the bears in 2023. Moreover, the U.S. economy’s third-quarter GDP surpassed growth estimates, easing recession fears to some extent. Therefore, this could be the right time to scoop up quality stocks Pfizer (PFE), Ryerson Holding…

StockNews.com

3 Stocks That Are Great for Passive Income Investors

Though the U.S. economy bounced back after shrinking in the first half of the year, falling consumer spending and the rate hikes to tame high inflation might lead the economy into a recession. Hence, investors looking for passive income could invest in fundamentally sound dividend-paying stocks Pfizer (PFE), Sanofi (SNY),…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

2 Health Care Stocks You Can Always Count On

With inflation showing no signs of slowing down, the chances of another 75-bps rate hike are increasing. Investing in healthcare stocks tends to help investors hedge against economic downturns. And given the sound prospects of the healthcare sector, fundamentally sound healthcare stocks Pfizer (PFE) and Humana (HUM) could be good…

StockNews.com

What Are Whales Doing With Pfizer

Someone with a lot of money to spend has taken a bullish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

3 Recession-Proof Stocks to Buy in October

Various headwinds, including the widespread fears of a recession, have kept the market clenched in a bear grip. Amid this backdrop, resilient stocks Pfizer (PFE), Waste Management (WM), and Ingles Markets (IMKTA), which belong to essential sectors and possess inelastic demand for their products or services, could be appropriate additions…

StockNews.com

4 Income Stocks You Could Buy and Hold Forever

As the central banks worldwide are determined to battle sky-high inflation with big rate hikes, top economists warn of a global recession on the way. While volatility is rife in the stock market, reliable dividend-paying stocks Pfizer (PFE), McKesson (MCK), Nutrien (NTR), and Genie Energy (GNE) might be ideal investments…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

This Pharmaceutical Stock Is Still a Smart Buy in 2022

Pfizer’s (PFE) co-developed COVID-19 vaccine booster for children, which recently got Emergency Use Authorization from the U.S. FDA, could boost its share price. The stock had witnessed significant attention during the pandemic and could still be worth owning. Let’s discuss this in detail….

StockNews.com

2 Stocks Under $50 You Shouldn’t Ignore in Q4

Sky-rocketing inflation and the Fed’s hawkish tilt have led to an economic slowdown. However, a decent start to the corporate earnings season is lifting investors’ optimism. And we think it will not be wise for investors to ignore fundamentally solid stocks such as Pfizer (PFE) and Kroger (KR), currently trading…

StockNews.com

3 Dividend Stocks to Buy That'll Pay You Forever

The Fed's consecutive aggressive interest rate hikes to combat record-high inflation have led to heightened volatility in the market. Dividend stocks could be ideal investments to generate stable income amid such unstable market conditions. Therefore, investors could consider buying fundamentally sound dividend stocks Pfizer (PFE), ICL Group (ICL), and Karooooo…

StockNews.com

2 Stocks to Buy Now That Won’t Put Your Portfolio at Risk

With inflation showing no sign of cooling down, the Fed is expected to continue with its rate hikes, raising the chances of a recession. Healthcare stocks have historically provided a cushion in such hazy times. Hence, fundamentally robust stocks Johnson & Johnson (JNJ) and Pfizer (PFE) might be safe additions…

StockNews.com

Looking At Pfizer's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

2 Stocks You'll Wish You Bought a Lot Earlier

The Fed's consistent rate hikes have wreaked havoc across markets. However, fundamentally solid stocks Pfizer (PFE) and CVS Health (CVS) survived the market volatility pretty well. While these stocks are good additions to your portfolio, you would have benefited more had you invested in them earlier. Read on….

StockNews.com

5 Stocks Under $50 to Buy This Week

Despite widespread recession concerns, Jim Cramer believes that the market could see an outsized rally in the near term as per historical trends. Given this backdrop, we think investors should load up Pfizer (PFE), Stellantis (STLA), APA Corporation (APA), Ryerson Holding (RYI), and Forrester Research (FORR), which are trading under…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

2 Stocks That Could Help You Fund Your Retirement

The stock market is experiencing a broad sell-off due to the Fed’s hawkish rate hikes and rising recession odds. As healthcare stocks are considered safe haven amid market turbulence, we think fundamentally sound Johnson & Johnson (JNJ) and Pfizer (PFE), which also have a significant dividend-paying record, could be solid…

Benzinga

Check Out What Whales Are Doing With PFE

StockNews.com

3 Stocks to Buy Now and Never Sell

Raging inflation and the Fed’s continued rate hikes have kept the stock market under tremendous pressure. Healthcare stocks have always been considered safe haven amid market uncertainties, and we think fundamentally solid stocks AbbVie (ABBV), Pfizer (PFE), and McKesson Corporation (MCK) could be ideal buys for the long term. Read…

StockNews.com

3 Dividend Stocks You Can Count on for Passive Income

The Fed’s successive rate hikes have hit household wealth. Moreover, rate hikes against a slowing economic backdrop have increased the risk of recession. Amid this, we believe stable dividend stocks Pfizer (PFE), Merck & Co. (MRK), and Valero Energy (VLO) might be ideal investments. Read more….

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Stocks You Will Want to Own Long Term

The interest rate hikes by central banks around the globe might slow down the global economy. However, staying invested in resilient and dividend-yielding stocks could help garner significant returns in the long run. To that end, Johnson & Johnson (JNJ), Pfizer (PFE), and Ryerson Holding Corporation (RYI) could be ideal…

StockNews.com

3 Safe Stocks You'll Want to Have Exposure to in 2022

The Fed’s aggressive monetary policies are raising recession fears. Amid such an environment, we think investors could consider adding AbbVie (ABBV), Pfizer (PFE), and Coca-Cola (KO) to their portfolios for stable returns. Read on to learn more….

StockNews.com

The 3 Best Stocks to Buy This Week

Despite looming recession fears, consumer confidence increased more than 4% month-over-month in September 2022. Against this backdrop, we believe quality stocks Pfizer (PFE), Comcast (CMCSA), and Microchip Technology (MCHP) could be ideal buys for you this week. Keep reading….

StockNews.com

2 Dividend Stocks to Double up on This Week

The stock market has been experiencing heightened volatility lately on concerns over the Fed’s aggressive rate hikes to tame record-high inflation and growing recession odds. Amid an uncertain market environment, investors increasingly take refuge in dividend stocks to ensure a steady income stream. Hence, it would be wise to invest…

StockNews.com

2 Earnings Winners to Scoop Up During the Bear Market

The bear market has been brutal. Given the trend in inflation and weakening economy, it's unlikely to end soon. For investors, the best strategy is to use the adverse market conditions to scoop up stocks that have a long-term history of compounding earnings. Therefore, investors should consider buying Builders FirstSource…

StockNews.com

5 Blue Chip Stocks to Help You Beat the Market Slump

Rising concerns over stubbornly-high inflation and the Fed’s commitment to bring it down to its desired level have kept equities under pressure lately. Amid increasing recessionary concerns, investing in blue-chip stocks such as Procter & Gamble (PG), AbbVie (ABBV), Pfizer (PFE), Dow (DOW), and Walgreens Boots Alliance (WBA) could help…

StockNews.com

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK),…

1 … 9 10 11 12

People

Kritika SarmahHer

727 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.